Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Aug;168(8):1640-1654.
doi: 10.1111/jnc.15907. Epub 2023 Jul 10.

A natural small molecule-mediated inhibition of alpha-synuclein aggregation leads to neuroprotection in Caenorhabditis elegans

Affiliations

A natural small molecule-mediated inhibition of alpha-synuclein aggregation leads to neuroprotection in Caenorhabditis elegans

Tulika Srivastava et al. J Neurochem. 2024 Aug.

Abstract

Small molecules are being explored intensively for their applications as therapeutic molecules in the management of metabolic and neurological disorders. The natural small molecules can inhibit protein aggregation and underlying cellular pathogenesis of neurodegenerative diseases involving multi-factorial mechanisms of action. Certain natural small molecular inhibitors of pathogenic protein aggregation are highly efficient and have shown promising therapeutic potential. In the present study, Shikonin (SHK), a natural plant-based naphthoquinone has been investigated for its aggregation inhibition activity against α-synuclein (α-syn) and the neuroprotective potential in Caenorhabditis elegans (C. elegans). SHK significantly inhibited aggregation of α-syn at sub-stochiometric concentrations, delayed the linear lag phase and growth kinetics of seeded and unseeded α-syn aggregation. The binding of SHK to the C-terminus of α-syn maintained α-helical and disordered secondary structures with reduced beta-sheet content and complexity of aggregates. Further, in C. elegans transgenic PD models, SHK significantly reduced α-syn aggregation, improved locomotor activity and prevented dopaminergic (DA) neuronal degeneration, indicating the neuroprotective role of SHK. The present study highlights the potential of natural small molecules in the prevention of protein aggregation that may further be explored for their therapeutic efficacy in the management of protein aggregation and neurodegenerative diseases.

Keywords: C. elegans; Parkinson's disease; aggregation inhibition; protein aggregation; shikonin; α‐synuclein.

PubMed Disclaimer

References

REFERENCES

    1. Abdulridha, M. K., al‐Marzoqi, A. H., al‐awsi, G. R. L., Mubarak, S. M. H., Heidarifard, M., & Ghasemian, A. (2020). Anticancer effects of herbal medicine compounds and novel formulations: A literature review. Journal of Gastrointestinal Cancer, 51(3), 765–773.
    1. Arosio, P., Knowles, T. P., & Linse, S. (2015). On the lag phase in amyloid fibril formation. Physical Chemistry Chemical Physics, 17(12), 7606–7618.
    1. Azimullah, S., Jayaraj, R. L., Meeran, M. F. N., Jalal, F. Y., Adem, A., Ojha, S., & Beiram, R. (2023). Myrcene salvages rotenone‐induced loss of dopaminergic neurons by inhibiting oxidative stress, inflammation, apoptosis, and autophagy. Molecules, 28(2), 685.
    1. Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N., & Bourne, P. E. (2000). The protein data bank. Nucleic Acids Research, 28(1), 235–242.
    1. Bieschke, J., Russ, J., Friedrich, R. P., Ehrnhoefer, D. E., Wobst, H., Neugebauer, K., & Wanker, E. E. (2010). EGCG remodels mature alpha‐synuclein and amyloid‐beta fibrils and reduces cellular toxicity. Proceedings of the National Academy of Sciences of the United States of America, 107(17), 7710–7715.

Publication types

MeSH terms

LinkOut - more resources